Excerpt: "Stern said that T-817MA could also go a step further and protect brain cells from destruction of Alzheimer's disease, which leads to dementia.'The changes in the brain in Alzheimer's disease start maybe 20 years before the first symptoms and then get worse and worse as the disease gets further along," said Stern. "If this drug would work, it would slow that progression so the person would be able to maintain a much better quality of life without deteriorating.' Stern said that would be a game changer for patients and their caregivers."